- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. 109MS305Publication without faculty affiliation
- Efficacy of a novel oral single-agent fumarate, BG00012, in patients with relapsing-remiting multiple sclerosis: results of a phase 2 studyPublication without faculty affiliation
- Safety and tolerability results of a phase 2b extension study of the novel oral fumarate BG00012 for the treatment of relapsing-remitting multiple sclerosisPublication without faculty affiliation
- Effect of BG-12 on contrast-enhanced lesions in patients with relapsing-remitting multiple sclerosis: subgroup analyses from the phase 2b study2012 | First Faculty of Medicine
- Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study2008 | Second Faculty of Medicine